CTRI/2024/03/063642尚未招募3 期
Modulation of Plasma phosphorylated tau181 (p-tau181) protein through Saraswata Ghrita nasya in Alzheimer’s Disease – An add on exploratory clinical trial - NI
Director of All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients between the age group of 50 to 80 years.
- •2.Patients of both genders.
- •3.Diagnosed case Diagnosed case of AD as per DSM IV criteria
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Kinetic Oscillation Stimulation (KOS) in chronic hemodialysis: new potential anti-inflammatory treatmentChronic inflammation in chronic dialysis patientsUrological and Genital DiseasesISRCTN49663124Karolinska University Hospital12
已完成
1 期
Functional role of translocator protein 18 kDa (TSPO) for stress regulationin healthy probands after treatment with anxiolytic compoundsstress in healthy subjectsDRKS00023318Medizinische Einrichtungen des Bezirks Oberpfalz60
进行中（未招募）
不适用
How valproic acid affects the body's own ability to dissolve blood clotsEUCTR2015-001092-49-SESahlgrenska Akademien Wallenberglaboratoriet
已完成
不适用
Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal DementiaPrimary Progressive AphasiaBehavioral Variant of Frontotemporal DementiaFrontotemporal Dementia, Behavioral VariantNCT02736695Mayo Clinic81
已完成
不适用
Evaluation of binding property to tau protein, systemic pharmacokinetics and effective dose of [11C]PBB3JPRN-UMIN000008242ational Institute of Radiological Sciences6